TMSB4X Antibody

What is TMSB4X and what cellular functions does it regulate?

TMSB4X (thymosin beta 4 X-linked) is a small 44 amino acid protein (5.1 kDa) primarily localized in the cytoplasm . It functions as an actin-sequestering protein that modulates the polymerization/depolymerization of actin through formation of a 1:1 complex with G-actin monomers, thereby inhibiting their polymerization into F-actin . This regulatory activity is critical for cytoskeletal organization . Beyond cytoskeletal regulation, TMSB4X has been found to:

• Stimulate secretion of hypothalamic luteinizing hormone-releasing hormone

• Inhibit peritoneal macrophage migration

• Induce phenotypic changes in T cell lines during early host defense

• Inhibit progression of hematopoietic pluripotent stem cells into S-phase

• Potentially contribute to heart repair by promoting endothelial cell migration

What applications are TMSB4X antibodies commonly used for?

TMSB4X antibodies are utilized across multiple immunodetection techniques:

Selection of the appropriate application depends on your specific research question. For cellular localization studies, ICC/IF is recommended, while WB provides information about expression levels and protein size verification .

How should researchers select the appropriate TMSB4X antibody for their experiment?

When selecting a TMSB4X antibody, consider these critical factors:

• Target species compatibility: Ensure the antibody has been validated for your species of interest. TMSB4X antibodies are available for human, mouse, and rat samples .

• Clonality:

  • Polyclonal antibodies (e.g., rabbit polyclonal) offer greater epitope coverage and higher sensitivity

  • Monoclonal antibodies provide higher specificity and batch-to-batch consistency

• Application validation: Verify the antibody has been tested for your specific application (WB, IHC, ICC, IP, ELISA) .

• Immunogen information: Check if the antibody was raised against the full-length protein (Met1~Ser44) or a specific region .

• Documentation: Review available images demonstrating successful detection in your application of interest .

When possible, select antibodies that have been cited in published literature for similar experimental conditions to ensure reliability .

How is TMSB4X expression correlated with cancer progression and prognosis?

TMSB4X has emerged as a significant biomarker in multiple cancer types with important prognostic implications:

Thyroid Cancer:

• TMSB4X expression is aberrantly upregulated in transformed thyroid cancer cells compared to normal/benign thyroid tissue

• Higher TMSB4X expression associates with:

  • Papillary tumor type (vs. follicular)

  • Older patient age at diagnosis

  • Extrathyroidal extension

  • Lymph node metastasis

  • BRAF V600E mutation

• Normal or benign thyroid follicular epithelium shows negative or minimal TMSB4X immunostaining

Head and Neck Squamous Cell Carcinoma (HNSCC):

• Identified as a significant biomarker through proteomics analysis

• Associated with enhanced proliferation and metastasis in vitro and in vivo

• Silencing TMSB4X reduces proliferation and invasion in HNSCC cell lines and inhibits cervical lymph node metastasis in vivo

These findings suggest TMSB4X may serve as both a prognostic marker and potential therapeutic target in multiple cancer types .

What methodological considerations are important when performing TMSB4X immunohistochemistry?

Successful TMSB4X immunohistochemistry requires careful attention to several methodological details:

• Tissue preparation:

  • Proper fixation (typically formalin-fixed paraffin-embedded)

  • Antigen retrieval is critical due to TMSB4X's small size and potential epitope masking

• Antibody selection and optimization:

  • Titrate antibody concentrations (typical working dilutions range from 1:100 to 1:200)

  • Include proper positive controls (lymphoid tissues express high levels of TMSB4X)

  • Include negative controls (omit primary antibody)

• Interpretation guidelines:

  • TMSB4X typically shows cytoplasmic staining patterns

  • May exhibit diffuse homogeneous staining or spot-like granular pattern with perinuclear accentuation

  • Occasionally nuclear staining is observed in cancer cells

• Quantification approaches:

  • H-score system (combines intensity and percentage of positive cells)

  • Can categorize expression as low (H-score 0-100), intermediate (101-200), or high (201-300)

  • Digital image analysis may provide more objective quantification

• Common artifacts and troubleshooting:

  • Background staining in inflammatory cells (TMSB4X is expressed in leukocytes)

  • Erythrocytes should be negative and can serve as internal negative controls

How does TMSB4X influence tumor immune microenvironment and potential immunotherapy responses?

TMSB4X appears to modulate the tumor immune microenvironment through several mechanisms:

• Dendritic cell function:

  • TMSB4X expression correlates positively with dendritic cell infiltration (R = 0.27)

  • May affect DC activation and antigen presentation capabilities

  • As an actin regulator, TMSB4X can influence DC morphology and migration

• Immune cell infiltration:

  • Computational analysis using the CIBERSORT algorithm shows correlation between TMSB4X expression and immune cell infiltration patterns in lung adenocarcinoma

  • High TMSB4X expression associates with increased stromal score and immune score (Spearman's rho = 0.606)

• Potential mechanisms:

  • TMSB4X regulates both G-actin and F-actin levels, with overexpression increasing G-actin and decreasing F-actin

  • F-actin is crucial for DC function in tumor antigen recognition and anti-tumor immune responses

  • TMSB4X overexpression may therefore impair DC function and facilitate immune evasion

• Therapeutic implications:

  • TMSB4X could represent a novel target to enhance immunotherapy responses

  • Inhibiting TMSB4X might improve DC function and anti-tumor immunity

  • Consideration as a companion biomarker for immunotherapy response prediction

What role does TMSB4X play in inflammation-associated ferroptosis?

Recent research has identified TMSB4X as an important regulator in the intersection between inflammation and ferroptosis, particularly in hepatocellular carcinoma (HCC):

• Mechanistic connections:

  • Ferroptosis (iron-dependent cell death) and inflammation exhibit significant cross-talk in cancer biology

  • Lipid peroxides generated during ferroptosis can accelerate tumor antigen recognition by dendritic cells

  • Inflammation can contribute to ferroptosis activation

• TMSB4X as a key regulator:

  • Identified through bioinformatics analysis and machine learning algorithms as an important gene in inflammation-associated ferroptosis

  • Potential biomarker and therapeutic target for HCC

• Experimental approaches:

  • siRNA knockdown studies using targeted sequences (e.g., si-TMSB4X-1: 5′-TAGCTGTTTAACTTTGTAAGATG-3′) help elucidate functional roles

  • Immunohistochemical analysis of HCC tissue microarrays can reveal expression patterns and clinical correlations

• Research implications:

  • Understanding TMSB4X's role in ferroptosis may reveal new therapeutic vulnerabilities

  • Potential for combination strategies targeting both inflammation and ferroptosis pathways

  • May explain prognostic significance of TMSB4X in various cancers

What controls and validation steps are essential when working with TMSB4X antibodies?

Rigorous controls are critical for reliable TMSB4X antibody-based experiments:

• Positive controls:

  • Cell lines with known TMSB4X expression (hemopoietic cell lines, lymphoid malignant cells)

  • Tissues with high endogenous expression (spleen, thymus, peritoneal macrophages)

  • Transfected cells overexpressing TMSB4X

• Negative controls:

  • Primary antibody omission

  • Isotype controls to assess non-specific binding

  • Non-transfected cells for comparison with TMSB4X-transfected samples

  • Erythrocytes (which do not express TMSB4X) within tissue sections

• Antibody validation techniques:

  • Knockdown/knockout verification: Use siRNA (e.g., si-TMSB4X-1, si-TMSB4X-2) to confirm signal specificity

  • Peptide competition assays to verify epitope specificity

  • Multiple antibody approach: Compare results using antibodies targeting different epitopes

• Technical validation:

  • Verify expected molecular weight (~5.1 kDa) in Western blots

  • Confirm expected subcellular localization (primarily cytoplasmic)

  • Assess batch-to-batch consistency with standard samples

Proper controls not only validate your findings but also help troubleshoot unexpected results.

How can researchers accurately quantify TMSB4X expression in heterogeneous tissue samples?

Quantifying TMSB4X in complex tissues presents several challenges:

• Immunohistochemical quantification approaches:

  • H-score system: Combines staining intensity (0-3) and percentage of positive cells

  • Can categorize as low (H-score 0-100), intermediate (101-200), or high (201-300)

  • Digital image analysis using specialized software improves objectivity

• Cell type-specific considerations:

  • TMSB4X is expressed in inflammatory infiltrates and stromal cells

  • In autoimmune thyroid disorders, positive staining in mononuclear and polymorphonuclear leukocytes but minimal in thyroid epithelial cells

  • Distinguish tumor cell expression from immune cell expression

• Transcriptomic analysis caveats:

  • RNA expression represents combined signal from tumor, stromal, and immune cells

  • TMSB4X expression correlates with stromal score and immune score

  • Consider microdissection or single-cell techniques for cell type-specific analysis

• Comparative methodologies:

  • Combine protein (IHC/WB) and mRNA (qPCR/RNA-seq) quantification

  • Correlate with clinicopathological parameters for biological validation

  • Consider multiplexed approaches to simultaneously assess TMSB4X and cell-type markers

This multi-faceted approach helps distinguish true biological variation from technical artifacts and provides more meaningful quantitative data.

What are emerging applications of TMSB4X antibodies in cancer research?

Several cutting-edge applications are expanding our understanding of TMSB4X in cancer:

• Liquid biopsy development:

  • Detection of TMSB4X peptide fragments in circulation as potential biomarkers

  • The tetrapeptide N-acetyl-Ser-Asp-Lys-Pro (degradation product of thymosin beta-4) has been found increased in intratumoral blood but not peripheral blood of papillary thyroid cancer patients

  • Potential for minimally invasive monitoring

• Spatial transcriptomics/proteomics integration:

  • Combining TMSB4X antibody-based detection with spatial genomics

  • MALDI imaging mass spectrometry (IMS) has identified TMSB4X as a tumor-associated biomarker in HNSCC

  • Understanding TMSB4X expression in the context of tumor microenvironment heterogeneity

• Therapeutic targeting strategies:

  • Antibody-drug conjugates targeting TMSB4X-expressing cells

  • Development of inhibitors targeting TMSB4X-dependent pathways

  • Rational combinations with immunotherapy based on TMSB4X's role in immune evasion

• Aging-related research:

  • Investigating the association between TMSB4X expression and patient age in cancer progression

  • TMSB4X expression increases with patient age in thyroid cancer

  • Potential connections to immune and inflammatory responses during aging

These emerging applications may significantly expand the utility of TMSB4X antibodies beyond their current research applications.

How might TMSB4X research contribute to precision medicine approaches?

TMSB4X holds significant potential for advancing precision medicine:

• Prognostic stratification:

  • TMSB4X expression correlates with poor prognosis in multiple cancers

  • Can help identify patients needing more aggressive treatment

  • H-score system for TMSB4X categorizes patients into prognostic groups

• Therapeutic target identification:

  • TMSB4X's role in cancer cell proliferation, invasion, and metastasis makes it a candidate therapeutic target

  • Silencing TMSB4X reduces proliferation and invasion in HNSCC cell lines

  • Could lead to development of targeted therapies

• Immunotherapy response prediction:

  • TMSB4X influences dendritic cell function and potentially tumor immune evasion

  • May serve as a biomarker for immunotherapy response

  • Could identify patients who might benefit from combination approaches

• Integration with molecular testing:

  • TMSB4X expression correlates with BRAF V600E mutation in thyroid cancer

  • Combining TMSB4X assessment with mutation testing may improve precision

  • Potential for inclusion in multifactorial prognostic and predictive algorithms

As research advances, TMSB4X assessment may become an important component of comprehensive cancer profiling for treatment decision-making.